SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 92 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $107,000 | -2.7% | 62,947 | 0.0% | 0.03% | -5.6% |
| Q2 2018 | $110,000 | -4.3% | 62,947 | 0.0% | 0.04% | -16.3% |
| Q1 2018 | $115,000 | -17.9% | 62,947 | 0.0% | 0.04% | -10.4% |
| Q4 2017 | $140,000 | -23.5% | 62,947 | 0.0% | 0.05% | -27.3% |
| Q3 2017 | $183,000 | -34.6% | 62,947 | 0.0% | 0.07% | -36.5% |
| Q2 2017 | $280,000 | -4.4% | 62,947 | 0.0% | 0.10% | -5.5% |
| Q1 2017 | $293,000 | -23.5% | 62,947 | 0.0% | 0.11% | -29.5% |
| Q4 2016 | $383,000 | +10.4% | 62,947 | 0.0% | 0.16% | +6.8% |
| Q3 2016 | $347,000 | +45.2% | 62,947 | 0.0% | 0.15% | +46.0% |
| Q2 2016 | $239,000 | +37.4% | 62,947 | 0.0% | 0.10% | +29.9% |
| Q1 2016 | $174,000 | +480.0% | 62,947 | +481.3% | 0.08% | +492.3% |
| Q3 2014 | $30,000 | -31.8% | 10,829 | 0.0% | 0.01% | -35.0% |
| Q2 2014 | $44,000 | – | 10,829 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
| Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
| ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
| Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
| Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
| Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
| DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
| PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
| WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |